3.9 Article

Maternal Enterovirus Infection during Pregnancy as a Risk Factor in Offspring Diagnosed with Type 1 Diabetes between 15 and 30 Years of Age

期刊

EXPERIMENTAL DIABETES RESEARCH
卷 -, 期 -, 页码 -

出版社

HINDAWI LTD
DOI: 10.1155/2008/271958

关键词

-

资金

  1. Swedish Childhood Diabetes Foundation
  2. Malmo Branch of the Swedish Diabetes Association, Lions Club International District [101-S]
  3. Novo Nordisk Insulin Fund
  4. UMAS funds
  5. Terry & Louise Gregg Diabetes in Pregnancy Award from the American Diabetes Association
  6. Skane County Council Foundation for Research and Development
  7. Juvenile Diabetes Research Foundation

向作者/读者索取更多资源

Maternal enterovirus infections during pregnancy may increase the risk of offspring developing type 1 diabetes during childhood. The aim of this study was to investigate whether gestational enterovirus infections increase the offspring's risk of type 1 diabetes later in life. Serum samples from 30 mothers without diabetes whose offspring developed type 1 diabetes between 15 and 25 years of age were analyzed for enterovirus-specific immunoglobulin M (IgM) antibodies and enterovirus genome (RNA), and compared to a control group. Among the index mothers, 9/30 (30%) were enterovirus IgM-positive, and none was positive for enterovirus RNA. In the control group, 14/90 (16%) were enterovirus IgM-positive, and 4/90 (4%) were positive for enterovirus RNA (n.s.). Boys of enterovirus IgM-positive mothers had approximately 5 times greater risk of developing diabetes (OR 4.63; 95% CI 1.22-17.6), as compared to boys of IgM-negative mothers (P < .025). These results suggest that gestational enterovirus infections may be related to the risk of offspring developing type 1 diabetes in adolescence and young adulthood.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.9
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Medicine, Research & Experimental

Enteroviruses and Type 1 Diabetes: Multiple Mechanisms and Factors?

Richard E. Lloyd, Manasi Tamhankar, Ake Lernmark

Summary: Type 1 diabetes is a chronic autoimmune disease characterized by insulin deficiency and hyperglycemia. Virus infections, particularly enteroviruses, are believed to play a potential role in triggering the disease. This review examines the association between enteroviruses and autoimmune development in Type 1 diabetes, as well as the molecular mechanisms involved.

ANNUAL REVIEW OF MEDICINE (2022)

Correction Biochemistry & Molecular Biology

A combined risk score enhances prediction of type 1 diabetes among susceptible children (vol 26, pg 1247, 2020)

Lauric A. Ferrat, Kendra Vehik, Seth A. Sharp, Ake Lernmark, Marian J. Rewers, Jin-Xiong She, Anette-G. Ziegler, Jorma Toppari, Beena Akolkar, Jeffrey P. Krischer, Michael N. Weedon, Richard A. Oram, William A. Hagopian

NATURE MEDICINE (2022)

Article Endocrinology & Metabolism

Rising Hemoglobin A1c in the Nondiabetic Range Predicts Progression of Type 1 Diabetes As Well As Oral Glucose Tolerance Tests

Kendra Vehik, David Boulware, Michael Killian, Marian Rewers, Richard McIndoe, Jorma Toppari, Ake Lernmark, Beena Akolkar, Anette-G. Ziegler, Henry Rodriguez, Desmond A. Schatz, Jeffrey P. Krischer, William Hagopian

Summary: This study suggests that an increase of >= 10% in HbA(1c) from baseline is as informative as OGTT 2-hPG in predicting the risk of stage 3 in children with diabetes-associated autoantibodies.

DIABETES CARE (2022)

Article Endocrinology & Metabolism

Predictors of the Initiation of Islet Autoimmunity and Progression to Multiple Autoantibodies and Clinical Diabetes: The TEDDY Study

Jeffrey P. Krischer, Xiang Liu, Ake Lernmark, William A. Hagopian, Marian J. Rewers, Jin-Xiong She, Jorma Toppari, Anette-G. Ziegler, Beena Akolkar

Summary: The objective of this study was to distinguish predictors of seroconversion, progression to multiple autoantibodies and from multiple autoantibodies to type 1 diabetes in young children. The results showed that different predictors were associated with the different types of first appearing autoantibodies. Factors such as male sex, Finnish residence, having a sibling with type 1 diabetes, specific genes, were associated with seroconversion. The predictors of progression to diabetes differed from the predictors of progression to multiple autoantibodies.

DIABETES CARE (2022)

Article Endocrinology & Metabolism

HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children

Falastin Salami, Roy Tamura, Lu You, Ake Lernmark, Helena Elding Larsson, Markus Lundgren, Jeffrey Krischer, Anette-Gabriele Ziegler, Jorma Toppari, Riitta Veijola, Marian Rewers, Michael J. Haller, William Hagopian, Beena Akolkar, Carina Torn

Summary: The study found that increased levels of HbA1c were associated with a higher risk of type 1 diabetes, while a decrease in HbA1c levels predicted the development of IA-2A autoantibody. The trajectory of HbA1c can predict the appearance of autoantibodies and the onset of type 1 diabetes.

PEDIATRIC DIABETES (2022)

Article Pediatrics

Islet autoantibody screening in at-risk adolescents to predict type 1 diabetes until young adulthood: a prospective cohort study

Mohamed Ghalwash, Vibha Anand, Olivia Lou, Frank Martin, Marian Rewers, Anette-G Ziegler, Jorma Toppari, William A. Hagopian, Riitta Veijola

Summary: Screening for islet autoantibodies in adolescents aged 10-18 can effectively predict the development of type 1 diabetes, allowing for education and prevention measures.

LANCET CHILD & ADOLESCENT HEALTH (2023)

Article Endocrinology & Metabolism

Physical Activity and the Development of Islet Autoimmunity and Type 1 Diabetes in 5-to 15-Year-Old Children Followed in the TEDDY Study

Xiang Liu, Suzanne Bennett Johnson, Kristian F. Lynch, Kerry Cordan, Russell Pate, Martha D. Butterworth, Ake Lernmark, William A. Hagopian, Marian J. Rewers, Richard A. McIndoe, Jorma Toppari, Anette-G. Ziegler, Beena Akolkar, Jeffrey P. Krischer, Jimin Yang, TEDDY Study Grp

Summary: This study found that increasing the daily duration of moderate to vigorous physical activity can reduce the risk of developing type 1 diabetes in children aged 5-15 who have multiple islet autoantibodies.

DIABETES CARE (2023)

Article Endocrinology & Metabolism

Interaction Between Dietary Iron Intake and Genetically Determined Iron Overload: Risk of Islet Autoimmunity and Progression to Type 1 Diabetes in the TEDDY Study

Steffen U. Thorsen, Xiang Liu, Yachana Kataria, Thomas Mandrup-Poulsen, Simranjeet Kaur, Ulla Uusitalo, Suvi M. Virtanen, Jill M. Norris, Marian Rewers, William Hagopian, Jimin Yang, Jin-Xiong She, Beena Akolkar, Stephen Rich, Carin Andren Aronsson, Ake Lernmark, Anette-Gabriele Ziegler, Jorma Toppari, Jeffrey Krischer, Hemang M. Parikh, Christina Ellervik, Jannet Svensson

Summary: It is found that iron intake and genetically determined iron overload may interact in predisposing to the development of childhood islet autoimmunity and type 1 diabetes. A U-shaped association between iron intake and risk of GAD antibody as the first autoantibody in children was found. High iron intake was associated with an increased risk of IA with insulin as the first autoantibody in children with 2 or more iron risk alleles.

DIABETES CARE (2023)

Review Medicine, General & Internal

Possible heterogeneity of initial pancreatic islet beta-cell autoimmunity heralding type 1 diabetes

Ake Lernmark, Beena Akolkar, William Hagopian, Jeffrey Krischer, Richard McIndoe, Marian Rewers, Jorma Toppari, Kendra Vehik, Anette-G. Ziegler, TEDDY Study Grp

Summary: The etiology of type 1 diabetes involves pancreatic islet beta-cell autoimmune pathogenesis that leads to the clinical onset of the disease. By testing autoantibodies against insulin, glutamic acid decarboxylase, islet antigen-2, and ZnT8 transporter, children can be monitored from birth until the appearance of the first islet autoantibody. The incidence rate of the first-appearing autoantibody follows two different patterns, and an innate immune reaction may precede the adaptive response.

JOURNAL OF INTERNAL MEDICINE (2023)

Editorial Material Medical Laboratory Technology

Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

David B. Sacks, Mark Arnold, George L. Bakris, David E. Bruns, Andrea R. Horvath, Ake Lernmark, Boyd E. Metzger, David M. Nathan, M. Sue Kirkman

Summary: This article summarizes the scientific evidence and recommendations for laboratory tests used in the diagnosis and management of patients with diabetes mellitus. The quality of the evidence supporting these tests varies, so an expert committee evaluated and compiled evidence-based recommendations. The guidelines were reviewed and revised based on feedback from reviewers and the public. They were then reviewed and approved by multiple professional organizations.

CLINICAL CHEMISTRY (2023)

Article Medical Laboratory Technology

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

David B. Sacks, Mark Arnold, George L. Bakris, David E. Bruns, Andrea R. Horvath, Ake Lernmark, Boyd E. Metzger, David M. Nathan, M. Sue Kirkman

Summary: This passage discusses the use of laboratory tests in the diagnosis and management of diabetes mellitus, and provides evidence-based recommendations for laboratory analysis in screening, diagnosis, or monitoring of diabetes.

CLINICAL CHEMISTRY (2023)

Article Endocrinology & Metabolism

Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

David B. Sacks, Mark Arnold, George L. Bakris, David E. Bruns, Andrea R. Horvath, Ake Lernmark, Boyd E. Metzger, David M. Nathan, M. Sue Kirkman

Summary: This article provides evidence-based recommendations for laboratory analysis in patients with diabetes, including diagnostic methods, monitoring of glycemic control, and measurement of other related markers. The recommendations are based on published data or expert consensus.

DIABETES CARE (2023)

Article Endocrinology & Metabolism

HLA Genotype and Probiotics Modify the Association Between Timing of Solid Food Introduction and Islet Autoimmunity in the TEDDY Study

Ulla Uusitalo, Lazarus K. Mramba, Carin Andren Aronsson, Kendra Vehik, Jimin Yang, Sandra Hummel, Ake Lernmark, Marian Rewers, William Hagopian, Richard Mcindoe, Jorma Toppari, Anette-G. Ziegler, Beena Akolkar, Jeffrey P. Krischer, Suvi M. Virtanen, Jill M. Norris, TEDDY Study Grp

Summary: This study aimed to investigate the interaction among HLA genotype, early probiotic exposure, and timing of complementary foods in relation to the risk of islet autoimmunity (IA). The results showed that early introduction of solid foods (<6 months) was associated with increased IA risk in children with the HLA DR3/4 genotype and no probiotic exposure during the first year of life. Introducing rice at 4-5.9 months, compared to other time periods in the US, was also associated with an increased risk of IA.

DIABETES CARE (2023)

Letter Medicine, General & Internal

SARS-CoV-2-No Increased Islet Autoimmunity or Type 1 Diabetes in Teens

Jeffrey P. Krischer, Ake Lernmark, William A. Hagopian, Marian J. Rewers, Richard McIndoe, Jorma Toppari, Anette-Gabriele Ziegler, Beena Akolkar

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Article Cell Biology

Plasma protein biomarkers predict the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity

Ernesto S. Nakayasu, Lisa M. Bramer, Charles Ansong, Athena A. Schepmoes, Thomas L. Fillmore, Marina A. Gritsenko, Therese R. Clauss, Yuqian Gao, Paul D. Piehowski, Bryan A. Stanfill, Dave W. Engel, Daniel J. Orton, Ronald J. Moore, Wei-Jun Qian, Salvatore Sechi, Brigitte I. Frohnert, Jorma Toppari, Anette-G. Ziegler, Ake Lernmark, William Hagopian, Beena Akolkar, Richard D. Smith, Marian J. Rewers, Bobbie-Jo M. Webb-Robertson, Thomas O. Metz, Teddy Study Grp

Summary: Type 1 diabetes (T1D) is caused by autoimmune destruction of b cells. The insufficient availability of biomarkers hinders understanding of the disease. This study identifies and validates biomarkers predictive of T1D development through plasma proteomics, highlighting the pathways affected during T1D progression.

CELL REPORTS MEDICINE (2023)

暂无数据